CREYTIVBI Trademark

Trademark Overview


On Monday, November 16, 2020, a trademark application was filed for CREYTIVBI with the United States Patent and Trademark Office. The USPTO has given the CREYTIVBI trademark a serial number of 79301796. The federal status of this trademark filing is REGISTERED as of Tuesday, June 29, 2021. This trademark is owned by NOVARTIS AG. The CREYTIVBI trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
creytivbi

General Information


Serial Number79301796
Word MarkCREYTIVBI
Filing DateMonday, November 16, 2020
Status700 - REGISTERED
Status DateTuesday, June 29, 2021
Registration Number6399134
Registration DateTuesday, June 29, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2021

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressCH

Trademark Events


Event DateEvent Description
Saturday, August 28, 2021NOTIFICATION PROCESSED BY IB
Tuesday, August 10, 2021FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, August 10, 2021FINAL DISPOSITION PROCESSED
Thursday, July 29, 2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Monday, July 12, 2021TEAS SECTION 7 REQUEST RECEIVED
Tuesday, June 29, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, April 13, 2021NOTIFICATION PROCESSED BY IB
Tuesday, April 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 24, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 23, 2021ASSIGNED TO EXAMINER
Wednesday, February 3, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 3, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 3, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, February 3, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 3, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 3, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 19, 2021APPLICATION FILING RECEIPT MAILED
Friday, January 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 14, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, January 7, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB